jx11502ma
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 4, 2020 (NCT05233657)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Serotonin 4 (5-HT4) receptorINHIBITOR
HTR4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06356389 | Phase 1/Phase 2 (Phase 2) | Mar 2, 2022 | Jiao Tong University, Jingxin |
| NCT05233657 | Phase 1 | Jan 4, 2020 | Jingxin |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jingxin | For profit | 2 | 2 | 2 | 2020 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1